Mibelle senolytic active takes aim at ‘zombie’ cells

Mibelle Biochemistry has taken the wraps off SenoCellTec, a next-generation senolytic active designed to rejuvenate the skin by targeting the root causes of ageing.

Through its unique clear – fill – revive mechanism, SenoCellTec clears senescent ‘zombie’ cells and activates skin stem cells to support deep regeneration and visibly restore skin vitality.

Skin ageing is driven by deeper biological processes like the accumulation of senescent zombie cells and the decline of skin stem cell activity.

Senescent cells release inflammatory signals that degrade collagen and disrupt regeneration, while aging stem cells lose their ability to renew the skin.

Together, these changes lead to reduced firmness, elasticity, and visible signs of ageing; addressing both factors is essential for lasting skin rejuvenation.

SenoCellTec clears away senescent zombie cells that accelerate aging by releasing harmful factors. Next, it fills the skin with new, functional cells by activating both dermal and epidermal stem cells. Finally, it revives skin vitality by boosting collagen production and improving elasticity.

Clinically tested, SenoCellTec significantly enhances hydration, firmness, elasticity, and density in just 28 days, while visibly reducing wrinkle depth - even in areas affected by gravity.

See more about Mibelle Biochemistry

Latest Issues

NYSCC Suppliers' Day 2026

Javits Center, New York
19 - 20 May

in-cosmetics Korea 2026

COEX, Seoul
1 - 3 July 2026